COVID-19 Study Launched at Intermountain Healthcare to Determine Whether Blood Thinners Prevent Clots, Illness Severity in Patients
As part of a national movement to develop treatments and therapies for COVID-19, Intermountain Healthcare researchers are launching a study in Utah to examine the effects of anticoagulants on patients who have tested positive for the novel coronavirus.
View full press release